Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
287(Pt 3), 957963
The study compared outcomes in those taking GLP-1 RAs versus DPP-4 inhibitors, revealing promising findings: Among 25,838 SLE patients, those on GLP-1 RAs had significantly fewer major cardiac events, such as heart attacks and strokes, compared to those on DPP-4 inhibitors
ClinicalTrials.gov identifiers NCT01572753, NCT01619345, NCT02014259, NCT02016911, NCT02249871, NCT02172313, NCT02877355
A Critique of Calorie Counting for Weight Loss: The Science Behind Calorie Deficits
The research was led by Isaac Harris, an associate professor in the Department of Biomedical Genetics, and colleagues including co-first authors Fabio Hecht and Marco Zocchi, both in the Harris Lab
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
